32 / 48
32
Preliminary Scientific Programme /
Symposia
WFSBP 2017
S-57-004
Genetic and central nervous system aspects of immune
dysregulation in Bipolar Disorder (BP)
Bartholomeus Haarman, The Netherlands
T51: NEURODEGENERATIVE DISORDERS
S-58
08:30–10:00
Novel therapeutics for neurodegenerative disorders
Chair:
Ramon Cacabelos García, Spain
S-58-001
ASS234, as a new multi-target directed propargylamine
for Alzheimer's Disease (AD) therapy
José Marco-Contelles, Spain
S-58-002
EB101 immunotherapy against amyloid: A promising
strategy for treating Alzheimer's Disease (AD)
Ivan Carrera, Spain
S-58-003
The Intelligent Pharmacogenetic Card (PGx-iCard) for
neuropsychiatric disorders
Juan C. Carril, Spain
S-58-004
Neuroprotective effects of Atremorine in Cerebral Isch-
emia and Parkinson disease-related models
Javier Egea, Spain
S-58-005
Basic and clinical studies with E-PodoFavalin-15999
(Atremorine®) in Parkinson's Disease: Selective dopami-
nergic neuroprotection and pharmacogenetics
Ramon Cacabelos, Spain
T22: MOLECULAR NEUROBIOLOGY
S-59
08:30–10:00
The relevance of Neuregulin1-ErbB4 signaling for
neuropsychiatric pathomechanisms: Converging
insights from mouse genetics, physiology, and human
studies
Chair:
Peter Falkai, Germany
Co-Chair: Moritz Rossner, Germany
S-59-001
The relevance of Neuregulin1-ErbB4 signaling for neu-
ropsychiatric pathomechanisms: Insights from human
studies
Cyndi Shannon Weickert, Australia
S-59-002
Neuregulin1-ErbB4 signaling: Integration at the network
level
Beatriz Rico, United Kingdom
S-59-003
The relevance of Neuregulin1-ErbB4: Insights from
mouse physiological analyses
Andrés Buonanno, USA
S-59-004
Neuregulin1-ErbB4 signaling: Insights from mouse
genetics
Markus Schwab, Germany
T22: MOLECULAR NEUROBIOLOGY
S-60
08:30–10:00
Multi-omics and psychiatry: The missing molecular link
Chair:
Michaela Filiou, Germany
Co-Chair: Anthony Zannas, Germany
S-60-001
Epigenomics of stress-related disorders: Current
evidence, limitations, and future directions
Anthony Zannas, Germany
S-60-002
From proteomics to biological mechanisms involved in
schizophrenia
Daniel Martins de Souza, Brazil
S-60-003
Multi-omics driven discovery of pharmacological targets
for stress-related disorders
Michaela Filiou, Germany
S-60-004
Role of CYP2C19 in major depressive disorder – transla-
tional study
Marin Jukic, Sweden
T49: SUICIDE: BASIC/CLINICAL
S-61
08:30–10:00
Suicide: Aspects that burn
Chair:
Konstantinos Fountoulakis, Greece
Co-Chair: Dina Popovic, Spain
S-61-001
Genetic basis of suicidal behaviour
Alessandro Serretti, Italy
S-61-002
Mixed features and suicidality: Is DSM 5 wrong?
Dina Popovic, Spain
THU